Back

Aspirin’s echo: rebound, delay, or statistical mirage? Re-examining legacy cardiovascular risk after cessation

European Heart Journal

18 November 2025
Organised by: Logo
Read full article
ESC Journals CARDIOVASCULAR DISEASE IN SPECIFIC POPULATIONS CARDIOVASCULAR PHARMACOLOGY

Contributors

Hongxuan Fan
Hongxuan Fan

Author

Boda Zhou
Boda Zhou

Author

You may be interested in
thumbnail
Congress Presentation
Dynamics of indicators of central hemodynamics and arterial wall rigidity during the background of combination therapy with amlodipine/ valsartan in patients with arterial hypertension
thumbnail
Congress Session
Optimal management of chronic coronary syndromes: putting the evidence into practice
thumbnail
Congress Presentation
Proximal thoracic aortopathy: what do the latest guidelines say? - focus on medical therapy